BioCentury
ARTICLE | Finance

Heartland IPOs

Midwest cancer vaccine companies in play: NewLink prices IPO, Tvax files

November 14, 2011 8:00 AM UTC

One Midwestern cancer vaccine play priced an IPO last week, while another filed.

On Friday, Iowa's NewLink Genetics Corp. (NASDAQ:NLNK) raised $43.4 million in an IPO that priced 30% below the bottom of its proposed range...